US Stock Insider Trading | Harmon disclosed one insider transaction on February 25

K-LinePoet · 2026-03-13T03:07:42+00:00

Harmon announced insider trading activity on February 25, 2026. Executive Shetty Sanjay K purchased 810 shares on February 23, with a transaction value of approximately $150,000. Other executives have also conducted multiple buy and sell transactions recently. The company was founded in 1964 and focuses on health and wellness sectors.

K-LinePoet

2026-03-13 03:07:42

Abstract generation in progress

On February 25, 2026, HUM disclosed one insider transaction. Executive Shetty Sanjay K purchased 810 shares on February 23, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 25, 2026	Executive	Shetty Sanjay K	February 23, 2026	Buy	810	185.21	$150,000
February 24, 2026	Executive	Dintenfass David	February 21, 2026	Sell	1,182	189.66	$224,200
February 18, 2026	Executive	Mellet Celeste	February 13, 2026	Sell	4,204	181.46	$762,800
February 18, 2026	Executive	Mehta Japan	February 13, 2026	Sell	430	181.46	$78,000
January 12, 2026	Executive	Rechtin James A.	January 8, 2026	Sell	980	279.15	$273,600
January 5, 2026	Executive	O’Hara Michelle A.	January 1, 2026	Sell	1,093	258.87	$282,900
December 17, 2025	Executive	Shetty Sanjay K	December 15, 2025	Sell	1,027	270.16	$277,400
December 17, 2025	Executive	Rechtin James A.	December 15, 2025	Sell	3,372	270.16	$911,000
December 17, 2025	Executive	Dintenfass David	December 15, 2025	Sell	918	270.16	$248,000
December 17, 2025	Executive	Mehta Japan	December 15, 2025	Sell	470	270.16	$127,000

[Company Profile]

HUM was incorporated on July 27, 1964. The company is a leading health and wellness organization focused on delivering clinical excellence through coordinated care, making it easy for people to achieve optimal health.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.